文献速递心血管妇产影像US

子痫前期:无症状性心力衰竭的重要危险因素

Pre-eclampsia: an important risk factor for asymptomatic heart failure.
PubMed 文献 · Ultrasound Obstet Gynecol · 2017-01-01

该横断面队列研究纳入107例既往子痫前期女性和41例既往妊娠平顺的对照,于产后4-10年行心脏超声、血压及代谢综合征指标评估。子痫前期组无症状性心力衰竭B期(HF-B)患病率约3.5倍于对照(25% vs 7%,P<0.01);校正产后间隔、高血压和高密度脂蛋白后,子痫前期与HF-B显著相关(校正OR 4.4,95%CI 1.0-19.1)。

要点

  • 既往子痫前期女性产后4-10年无症状性HF-B患病率25%,对照为7%。
  • 子痫前期组HF-B者中67%为向心性重构,22%为射血分数轻度受损。
  • 校正产后间隔、高血压和高密度脂蛋白后,子痫前期与HF-B独立相关(校正OR 4.4)。

核心结论

  • 子痫前期与女性无症状性心脏异常风险约增加四倍相关;子痫前期组中高血压前期似乎显著增加该风险,而代谢综合征决定因素未见此关联。

研究设计与样本

  • 横断面队列研究,纳入107例既往子痫前期女性和41例既往妊娠平顺的对照,于产后4-10年行心脏超声、血压测量及代谢综合征决定因素评估;按美国心脏协会指南将无症状结构和功能心脏异常分类为HF-B。

关键影像表现/征象

  • 子痫前期组HF-B者中67%表现为向心性重构,22%表现为射血分数轻度受损。

诊断标准与关键数值

  • 无症状结构和功能心脏异常按美国心脏协会指南分类为HF-B。
  • 高血压前期定义为收缩压120-139 mmHg和/或舒张压80-89 mmHg。
  • 子痫前期组HF-B患病率25% vs 对照组7%,P<0.01。
  • 校正产后间隔、高血压和高密度脂蛋白后,子痫前期与HF-B相关:校正OR 4.4(95%CI 1.0-19.1)。
  • 子痫前期组中高血压前期与HF-B相关:OR 4.3(95%CI 1.4-12.7);代谢综合征决定因素与HF-B无显著关联。

临床应用与阅片要点

  • 对既往子痫前期女性行心脏超声评估时,应关注向心性重构和射血分数轻度受损等HF-B表现。
  • 报告时应结合血压状态,高血压前期(收缩压120-139 mmHg和/或舒张压80-89 mmHg)与HF-B风险升高相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Pre-eclampsia (PE) is associated with both postpartum structural asymptomatic heart disease (i.e. heart failure Stage B (HF-B)) and conventional cardiovascular (CV) risk factors. We aimed to evaluate the extent to which PE, adjusted for conventional CV risk factors, is associated independently with asymptomatic cardiac abnormalities postpartum.

METHODS: In this cross-sectional cohort study, 107 formerly pre-eclamptic women and 41 women with uneventful previous pregnancy (controls) were invited for CV risk assessment 4-10 years postpartum. This included cardiac ultrasound, blood pressure (BP) measurement and evaluation of metabolic syndrome determinants. Asymptomatic structural and functional cardiac abnormalities were classified as HF-B, according to the American Heart Association guidelines. Prehypertension was defined as systolic BP of 120-139 mmHg and/or diastolic BP of 80-89 mmHg. Univariate and multivariate regression analyses were performed to calculate associations of PE and conventional risk factors with HF-B.

RESULTS: The prevalence of asymptomatic HF-B was approximately 3.5-fold higher in the PE group compared with controls (25% vs 7%, P < 0.01); 67% of this group had concentric remodeling and 22% had mildly impaired ejection fraction. After adjustment for postpartum interval, hypertension and high-density lipoprotein, PE was significantly associated with HF-B (adjusted odds ratio, 4.4 (95% CI, 1.0-19.1)). Moreover, in the formerly pre-eclamptic group, prehypertension was associated significantly with HF-B (odds ratio, 4.3 (95% CI, 1.4-12.7)), while metabolic syndrome determinants were not.

CONCLUSION: PE is associated with a four-fold increased female-specific risk of asymptomatic cardiac abnormalities. Prehypertension apparently increases this risk significantly, while metabolic syndrome determinants do not. Copyright © 2016 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Ghossein-Doha C, van Neer J, Wissink B, et al. Pre-eclampsia: an important risk factor for asymptomatic heart failure. Ultrasound Obstet Gynecol. 2017. PMID: 27804179. doi:10.1002/uog.17343

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。